Zepbound (tirzepatide) is a prescription drug used to help with weight loss and sleep apnea in certain ... for OSA is the same as shown in this chart, except that the typical maintenance dosage ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Tirzepatide is available through both the type 2 diabetes medication Mounjaro and weight-loss medication Zepbound. A new study funded by Eli Lilly reports that people without diabetes can lose up ...

Zepbound is a brand-name drug prescribed for weight loss and long-term weight maintenance in certain adults with obesity or overweight. Zepbound is also approved to treat severe obstructive sleep ...

Eli Lilly has lowered the price of its weight-loss drug Zepbound for patients paying out of pocket and introduced two new available vial doses.

By Rebecca Robbins It’s easy to make a medical case for blockbuster weight loss drugs like Wegovy and Zepbound, which have been shown to prevent heart attacks and strokes and save lives.

Eli Lilly & Co. said Tuesday it’s cutting the price of single-dose vials of its Zepbound treatment for ... there’s no longer a shortage of weight-loss drugs that had allowed for alternatives ...

Eli Lilly is expanding the supply and cutting the costs of its weight-loss drug Zepbound, broadening access to more patients without insurance. The company launched 7.5 mg and 10 mg vials of ...

Investing.com - Eli Lilly (NYSE:LLY) announced on Tuesday that it would begin selling 7.5 milligram and 10 milligram single-dose vials of its Zepbound weight-loss drug at a roughly $150 discount ...

Eli Lilly on Tuesday released higher doses of its weight loss drug Zepbound in single-dose vials at as much as half its usual monthly list price to reach more patients without insurance coverage ...